CLOV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CLOV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Clover Health Investments's enterprise value is $107 Mil. Clover Health Investments's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,034 Mil. Therefore, Clover Health Investments's EV-to-Revenue for today is 0.05.
The historical rank and industry rank for Clover Health Investments's EV-to-Revenue or its related term are showing as below:
During the past 5 years, the highest EV-to-Revenue of Clover Health Investments was 9.62. The lowest was -0.08. And the median was 0.25.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-05-05), Clover Health Investments's stock price is $0.695. Clover Health Investments's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $4.23. Therefore, Clover Health Investments's PS Ratio for today is 0.16.
The historical data trend for Clover Health Investments's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
EV-to-Revenue | - | - | 0.79 | 0.03 | 0.11 |
Clover Health Investments Quarterly Data | |||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-Revenue | Get a 7-Day Free Trial | 0.03 | - | -0.03 | 0.01 | 0.11 |
For the Healthcare Plans subindustry, Clover Health Investments's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Clover Health Investments's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 106.559 | / | 2033.72 | |
= | 0.05 |
Clover Health Investments's current Enterprise Value is $107 Mil.
Clover Health Investments's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,034 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments (NAS:CLOV) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Clover Health Investments's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 0.695 | / | 4.227 | |
= | 0.16 |
Clover Health Investments's share price for today is $0.695.
Clover Health Investments's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Clover Health Investments's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Karen Soares | officer: General Counsel & Secretary | 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Clover Health Investments, Corp. /de | officer: Chief Technology Officer | 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Anna U Loengard | director | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Andrew Toy | director, officer: Chief Executive Officer | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067 |
Scott J. Leffler | officer: Chief Financial Officer | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Brady Patrick Priest | officer: CEO of Home Care | C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067 |
Demetrios L. Kouzoukas | director | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067 |
Aric R Sharp | officer: CEO of Value-Based Care | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Wai Conrad | officer: Chief Technology Officer | 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Joseph Richards Martin | officer: General Counsel | C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219 |
Vivek Garipalli | director, 10 percent owner, officer: Executive Chairperson | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067 |
Carladenise Armbrister Edwards | director | C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067 |
Chelsea Clinton | director | C/O IAC 555 W 18TH STREET, NEW YORK NY 10011 |
Jamie L. Reynoso | officer: CEO of Medicare Advantage | C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067 |
Chamath Palihapitiya | 10 percent owner, other: See Remarks | THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025 |
From GuruFocus
By Value_Insider Value_Insider • 12-13-2022
By Value_Insider Value_Insider • 11-30-2022
By Ds*** Ds*** • 08-31-2022
By Marketwired • 10-12-2023
By sperokesalga sperokesalga • 04-24-2023
By sperokesalga sperokesalga • 02-22-2023
By Marketwired • 08-02-2023
By Marketwired • 08-01-2023
By Marketwired • 09-20-2023
By sperokesalga sperokesalga • 04-17-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.